0001759778-21-000001.txt : 20210430 0001759778-21-000001.hdr.sgml : 20210430 20210430132506 ACCESSION NUMBER: 0001759778-21-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20210430 DATE AS OF CHANGE: 20210430 EFFECTIVENESS DATE: 20210430 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Pattern Pharma Inc. CENTRAL INDEX KEY: 0001759778 IRS NUMBER: 000000000 STATE OF INCORPORATION: A6 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-397779 FILM NUMBER: 21875921 BUSINESS ADDRESS: STREET 1: 31 RIDGE DR. CITY: TORONTO STATE: A6 ZIP: M4T 1B6 BUSINESS PHONE: 416-302-5155 MAIL ADDRESS: STREET 1: 31 RIDGE DR. CITY: TORONTO STATE: A6 ZIP: M4T 1B6 D 1 primary_doc.xml X0708 D LIVE 0001759778 Pattern Pharma Inc. 31 RIDGE DR. TORONTO A6 ONTARIO, CANADA M4T 1B6 416-302-5155 ONTARIO, CANADA None None Corporation true 2018 Mark Frans van Coeverden de Groot 31 RIDGE DR. TORONTO A6 ONTARIO, CANADA M4T 1B6 Executive Officer Director Andrew Williams 31 RIDGE DR. TORONTO A6 ONTARIO, CANADA M4T 1B6 Executive Officer Hans Kierstead 31 RIDGE DR. TORONTO A6 ONTARIO, CANADA M4T 1B6 Director Nick Glover 31 RIDGE DR. TORONTO A6 ONTARIO, CANADA M4T 1B6 Executive Officer Pharmaceuticals No Revenues 06b false 2021-04-16 true true true true This Special Equity Right Certificate represents the right for the investment to automatically convert into shares of the Issuer in a subsequent offering until March 31, 2024. false 0 50000 50000 0 false 1 0 0 0 In the ordinary course of business, the issuer may use some of the proceeds of the offering to pay salaries to certain of its executive officers and directors. false Pattern Pharma Inc. Mark de Groot Mark de Groot Chief Executive Officer 2021-04-30